Do you want to access to this and other private contents?
Log in if you are a subscriber or click here to request service

Dr. Schär closes 2023 with 561 million euro turnover (+16.8%)

With 48 million investments, the South Tyrolean company aims to strengthen itself in South America and the Middle East

For Dr. Schär, a gluten-free and specific nutrition company, the trend was positive in all geographical areas, with Italy remaining among the most important markets. The South Tyrolean company consolidates its leadership and continues its growth strategy, aiming for 600 million euros in global turnover in 2024.Dr. Schär closed the 2023 financial year on a positive note with a global turnover of 561 m...

lml - 39303
Postal, BZ, Italy, 03/21/2024 13:56
EFA News - European Food Agency

Similar

GlutenfreeDr. Schär: 2025 turnover of €632 million

Investments of 28 million euros are planned, particularly in Italy, Spain and Germany.

Dr. Schär closed 2025 with a 1.3% increase in global revenue, reaching €632 million compared to €624 million in 2024. These results are supported by an integrated strategy based on internationalization, the... more

GlutenfreeDr. Schär: 2024 turnover rises to 624 million euros

Gluten-free company invests 45 million in innovation and expansion abroad

Dr. Schär, a South Tyrolean gluten-free and specific nutrition company, closed the 2024 financial year with a global turnover of 624 million euros, up 11% compared to the previous year. The trend was... more

GlutenfreeDr. Schaer takes over plant in Finland

Acquired Hero's gluten-free operations in the Nordic countries

Dr. Schaer, an Italian company specializing in foods for special diets, has announced that it has taken over the "gluten free" business of Hero in the Nordic countries. The transaction will be completed... more